What is Papillon Center?
Led by Dr. Christine McGinn, Papillon Center operates as a premier provider of gender-affirming medical services. The facility specializes in Sex Reassignment Surgery (SRS), Hormone Replacement Therapy (HRT), and professional electrolysis services. By integrating comprehensive surgical expertise with ongoing hormonal support, the center addresses a critical gap in the healthcare market. Their commitment to accessibility is further evidenced by their integration of health insurance coverage and flexible financing options, ensuring that high-quality, life-affirming care remains attainable for the transgender community.
How much funding has Papillon Center raised?
Papillon Center has raised a total of $85K across 1 funding round:
Debt
$85K
Debt (2021): $85K with participation from PPP
Key Investors in Papillon Center
PPP
Public-Private Partnership
What's next for Papillon Center?
With the recent infusion of capital, Papillon Center is expected to prioritize the expansion of its surgical capacity and the modernization of its clinical infrastructure. As the demand for specialized gender-affirming care continues to rise, the organization is well-positioned to capture additional market share by optimizing patient throughput and investing in advanced medical technologies. Future strategic initiatives will likely focus on broadening the scope of their multidisciplinary care teams and potentially expanding their geographic footprint to serve a wider patient demographic, thereby solidifying their status as a leader in the field of gender-affirming medicine.
See full Papillon Center company page
